Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has a beta value of 0.94 and has seen 0.4 million shares traded in the last trading session. The company, currently valued at $5.29M, closed the last trade at $0.36 per share which meant it lost -$0.04 on the day or -10.55% during that session. The VRPX stock price is -1422.22% off its 52-week high price of $5.48 and 19.44% above the 52-week low of $0.29. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.74 million shares traded. The 3-month trading volume is 3.74 million shares.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Sporting -10.55% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the VRPX stock price touched $0.36 or saw a rise of 19.88%. Year-to-date, Virpax Pharmaceuticals Inc shares have moved -6.53%, while the 5-day performance has seen it change -6.53%. Over the past 30 days, the shares of Virpax Pharmaceuticals Inc (NASDAQ:VRPX) have changed 6.73%. Short interest in the company has seen 0.35 million shares shorted with days to cover at 1.04.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 88.0% from current levels. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the current price level is -733.33% off the targeted high while a plunge would see the stock gain -733.33% from current levels.
Virpax Pharmaceuticals Inc (VRPX) estimates and forecasts
The company’s shares have lost -79.11% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -20.69% over the past 5 years.
VRPX Dividends
Virpax Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Insiders own 3.72% of the company shares, while shares held by institutions stand at 1.90% with a share float percentage of 1.97%. Investors are also buoyed by the number of investors in a company, with Virpax Pharmaceuticals Inc having a total of 10.0 institutions that hold shares in the company. The top two institutional holders are PARALLEL ADVISORS, LLC with over 1.0 shares worth more than $1.0. As of 2024-06-30, PARALLEL ADVISORS, LLC held 0.0001% of shares outstanding.
